BELCANTO · Improvement of Quality of Life by Cannabinoids in Oncologic Patients
Trial terminated
Also in this update: Final enrollment: 79 participants (planned 170); Primary completion date changed from estimate of Nov 30, 2026 to Feb 5, 2026
University Hospital Schleswig-HolsteinPhase 2 NCT06097533 Registry history of NCT06097533 on ClinicalTrials.gov (opens the registry)